Comparison of peripheral blood stem cell transplant with bone marrow transplant in class 3 thalassemic patients.

Abstract

These results showed that stem cell transplant is an effective treatment in class 3 thalassemic patients with the outcome relatively similar to bone marrow transplant. Although engraftment time is shorter in peripheral blood stem cell transplant method, it is associated with higher rate of chronic graft-versus-host disease.